Loading...
Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
CRISPR/Cas has opened the prospect of direct gene correction therapy for some inherited retinal diseases. Previous work has demonstrated the utility of adeno-associated virus (AAV) mediated delivery to retinal cells in vivo; however, with the expanding repertoire of CRISPR/Cas endonucleases, it is n...
Saved in:
| Published in: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511709/ https://ncbi.nlm.nih.gov/pubmed/33132845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2020.570917 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|